Pfizer Jumps Back Into Obesity With $4.9bn Bid For Metsera

 
• By Joseph Haas
  
Two people shaking hands
Pfizer agrees to buy obesity specialist Metsera (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business